Literature DB >> 14684303

The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).

Prakash G Jagtap1, Garry J Southan, Erkan Baloglu, Siya Ram, Jon G Mabley, Anita Marton, Andrew Salzman, Csaba Szabó.   

Abstract

A series of novel 4-(N-acyl)-2,3-dihydro-1H-isoindol-1-ones have been prepared from methyl-3-nitro-2-methylbenzoate and linked through various spacers to the adenosine derivatives 11 and 12. We found that potent inhibition of poly(ADP-ribose)polymerase-1 (PARP-1) was achieved when isoindolinone was linked to adenosine by a spacer group of a specific length. Introduction of piperazine and succinyl linkers between the isoindolinone and adenosine core structures resulted in highly potent compounds 8a and 10b, which showed IC(50) values of 45 and 100 nM, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684303     DOI: 10.1016/j.bmcl.2003.10.007

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Parallel synthesis of a series of non-functional ATP/NAD analogs with activity against trypanosomatid parasites.

Authors:  Andreas Link; Philipp Heidler; Marcel Kaiser; Reto Brun
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

2.  Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.

Authors:  Teemu Haikarainen; Mohit Narwal; Päivi Joensuu; Lari Lehtiö
Journal:  ACS Med Chem Lett       Date:  2013-11-20       Impact factor: 4.345

3.  PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain.

Authors:  Jennine M Dawicki-McKenna; Marie-France Langelier; Jamie E DeNizio; Amanda A Riccio; Connie D Cao; Kelly R Karch; Michael McCauley; Jamin D Steffen; Ben E Black; John M Pascal
Journal:  Mol Cell       Date:  2015-11-25       Impact factor: 17.970

4.  Structural basis for allosteric PARP-1 retention on DNA breaks.

Authors:  Levani Zandarashvili; Marie-France Langelier; Uday Kiran Velagapudi; Mark A Hancock; Jamin D Steffen; Ramya Billur; Zain M Hannan; Andrew J Wicks; Dragomir B Krastev; Stephen J Pettitt; Christopher J Lord; Tanaji T Talele; John M Pascal; Ben E Black
Journal:  Science       Date:  2020-04-03       Impact factor: 47.728

5.  Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D.

Authors:  Jon G Mabley; Rebecca Wallace; Pál Pacher; Kanneganti Murphy; Csaba Szabó
Journal:  Int J Mol Med       Date:  2007-06       Impact factor: 4.101

Review 6.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

7.  A versatile strategy for the design and synthesis of novel ADP conjugates and their evaluation as potential poly(ADP-ribose) polymerase 1 inhibitors.

Authors:  Yuliya V Sherstyuk; Alexandra L Zakharenko; Mikhail M Kutuzov; Polina V Chalova; Maria V Sukhanova; Olga I Lavrik; Vladimir N Silnikov; Tatyana V Abramova
Journal:  Mol Divers       Date:  2016-09-27       Impact factor: 2.943

Review 8.  Regulated necrosis: disease relevance and therapeutic opportunities.

Authors:  Marcus Conrad; José Pedro Friedmann Angeli; Peter Vandenabeele; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

Review 9.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007

10.  Parallel solution-phase synthesis of an adenosine antibiotic analog library.

Authors:  Omar Moukha-chafiq; Robert C Reynolds
Journal:  ACS Comb Sci       Date:  2013-02-11       Impact factor: 3.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.